0001437749-24-017053.txt : 20240515 0001437749-24-017053.hdr.sgml : 20240515 20240515161134 ACCESSION NUMBER: 0001437749-24-017053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeMaitre George W CENTRAL INDEX KEY: 0001365737 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 24950765 MAIL ADDRESS: STREET 1: 342 BUNKER HILL STREET, #2B CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0508 4 2024-05-13 0001158895 LEMAITRE VASCULAR INC LMAT 0001365737 LeMaitre George W C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 Chairman and CEO 1 Common Stock 2024-05-13 4 S 0 35826 76.4162 D 2043302 D Common Stock 2024-05-14 4 G 0 4000 0 D 2039302 D Common Stock 2024-05-14 4 S 0 40968 76.80070 D 1998334 D The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.24 to $76.60. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Adoption date of referenced 10b5-1(c) plan is: 06-02-2023 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.60 to $77.07. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. /s/ Nathaniel R.J. Ulrich 2024-05-15